Fox Run Management, L.L.C. Abbott Laboratories Transaction History

Fox Run Management, L.L.C.

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$100.73 - $112.44 $1.48 Million - $1.65 Million	14,658 New	14,658 $1.52 Million
Q4 2023 Feb 13, 2024	SELL	$90.19 - $110.4 $429,394 - $525,614	-4,761 Reduced 56.52%	3,662 $403,000
Q3 2023 Nov 07, 2023	BUY	$95.53 - $114.62 $804,649 - $965,444	8,423 New	8,423 $815,000
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $567,713 - $686,183	-5,562 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$114.02 - $139.04 $207,630 - $253,191	1,821 Added 48.68%	5,562 $658,000
Q4 2021 Feb 09, 2022	BUY	$115.53 - $141.46 $13,054 - $15,984	113 Added 3.11%	3,741 $527,000
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $423,242 - $468,229	3,628 New	3,628 $429,000
Q3 2020 Oct 29, 2020	SELL	$91.64 - $111.29 $398,817 - $484,334	-4,352 Closed	0 $0
Q2 2020 Jul 31, 2020	SELL	$76.57 - $98.0 $25,421 - $32,536	-332 Reduced 7.09%	4,352 $398,000
Q2 2019 Jul 17, 2019	BUY	$72.88 - $85.0 $341,369 - $398,140	4,684 New	4,684 $394,000
Q1 2019 Oct 17, 2019	SELL	$66.22 - $80.06 $235,345 - $284,533	-3,554 Closed	0 $0
Q4 2018 Jan 15, 2019	BUY	$65.56 - $74.27 $233,000 - $263,955	3,554 New	3,554 $257,000
Q2 2018 Jul 17, 2018	SELL	$57.57 - $63.54 $748,122 - $825,702	-12,995 Closed	0 $0
Q1 2018 Apr 17, 2018	BUY	$56.27 - $63.62 $361,309 - $408,504	6,421 Added 97.67%	12,995 $779,000
Q4 2017 Jan 18, 2018	SELL	$53.68 - $57.47 $339,579 - $363,555	-6,326 Reduced 49.04%	6,574 $375,000
Q3 2017 Oct 23, 2017	BUY	$48.06 - $53.64 $619,974 - $691,956	12,900	12,900 $688,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fox Run Management, L.L.C. with notifications on news.